18048828

Source:http://linkedlifedata.com/resource/pubmed/id/18048828

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0085101, umls-concept:C0599894, umls-concept:C0920321, umls-concept:C1334596, umls-concept:C1521840
pubmed:issue	34
pubmed:dateCreated	2007-11-30
pubmed:abstractText	Tumors metastasizing to the CNS and leptomeninges (LM) are associated with significant mortality. We tested the toxicity, pharmacokinetics, and dosimetry of intraventricular iodine-131-labeled monoclonal antibody 3F8 (131I-3F8) targeting GD2-positive CNS/LM disease in a phase I clinical trial.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA72868
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/3F8 antibody, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G, http://linkedlifedata.com/resource/pubmed/chemical/Immunotoxins, http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1527-7755
pubmed:author	pubmed-author:CheungNai-Kong VNK, pubmed-author:DunkelIra JIJ, pubmed-author:FinnRonald DRD, pubmed-author:GeraldWilliam LWL, pubmed-author:HummJohn LJL, pubmed-author:KhakooYasminY, pubmed-author:KramerKimK, pubmed-author:LarsonSteven MSM, pubmed-author:SouweidaneMark MMM, pubmed-author:WoldenSuzanne LSL, pubmed-author:YehSamuel DSD, pubmed-author:YeungHenry WHW, pubmed-author:ZanzonicoPat BPB
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	25
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	5465-70
pubmed:meshHeading	pubmed-meshheading:18048828-Adolescent, pubmed-meshheading:18048828-Adult, pubmed-meshheading:18048828-Animals, pubmed-meshheading:18048828-Antibodies, Monoclonal, pubmed-meshheading:18048828-Cerebellar Neoplasms, pubmed-meshheading:18048828-Child, pubmed-meshheading:18048828-Child, Preschool, pubmed-meshheading:18048828-Humans, pubmed-meshheading:18048828-Immunoglobulin G, pubmed-meshheading:18048828-Immunotoxins, pubmed-meshheading:18048828-Infant, pubmed-meshheading:18048828-Iodine Radioisotopes, pubmed-meshheading:18048828-Medulloblastoma, pubmed-meshheading:18048828-Meningeal Neoplasms, pubmed-meshheading:18048828-Mice, pubmed-meshheading:18048828-Mice, Inbred BALB C, pubmed-meshheading:18048828-Middle Aged, pubmed-meshheading:18048828-Neuroblastoma, pubmed-meshheading:18048828-Radioimmunotherapy
pubmed:year	2007
pubmed:articleTitle	Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8.
pubmed:affiliation	Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. kramerk@mskcc.org
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't, Clinical Trial, Phase I, Research Support, N.I.H., Extramural